Rxcurve
HCPCS J0850 · per PER VIAL

Cytomegalovirus imm iv /vial

Products billed under this code include Cytogam.

Payment limit per PER VIAL, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0850

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Cytogam Kamada Ltd. 49591-0532-51 1 $1,857.125

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1,857.125 −$1.696 PER VIAL Cytomegalovirus imm iv /vial v1, posted September 17, 2026
3Q26 $1,858.821 +$50.214 PER VIAL Cytomegalovirus imm iv /vial v1, posted September 15, 2026
2Q26 $1,808.607 +$0.278 PER VIAL Cytomegalovirus imm iv /vial v1, posted September 15, 2026
1Q26 $1,808.329 −$0.316 PER VIAL Cytomegalovirus imm iv /vial v1, posted September 15, 2026
4Q25 $1,808.645 −$0.799 PER VIAL Cytomegalovirus imm iv /vial v1, posted September 8, 2026
3Q25 $1,809.444 −$2.563 PER VIAL Cytomegalovirus imm iv /vial v1, posted March 10, 2026
2Q25 $1,812.007 −$2.101 PER VIAL Cytomegalovirus imm iv /vial v1, posted March 10, 2026
1Q25 $1,814.108 −$0.83 PER VIAL Cytomegalovirus imm iv /vial v1, posted December 19, 2025
4Q24 $1,814.938 +$2.801 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 11, 2025
3Q24 $1,812.137 +$3.915 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 11, 2025
2Q24 $1,808.222 +$0.35 PER VIAL Cytomegalovirus imm iv /vial v1, posted March 11, 2025
1Q24 $1,807.872 +$140.286 PER VIAL Cytomegalovirus imm iv /vial v1, posted December 19, 2024
4Q23 $1,667.586 −$146.609 PER VIAL Cytomegalovirus imm iv /vial v1, posted October 10, 2024
3Q23 $1,814.195 −$0.424 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 5, 2024
2Q23 $1,814.619 +$45.052 PER VIAL Cytomegalovirus imm iv /vial v1, posted February 23, 2024
1Q23 $1,769.567 +$102.859 PER VIAL Cytomegalovirus imm iv /vial v1, posted December 6, 2023
4Q22 $1,666.708 +$12.051 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 22, 2023
3Q22 $1,654.657 +$128.075 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 9, 2023
2Q22 $1,526.582 +$1.124 PER VIAL Cytomegalovirus imm iv /vial v1, posted December 14, 2022
1Q22 $1,525.458 −$13.241 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 8, 2022
4Q21 $1,538.699 +$18.047 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 2, 2022
3Q21 $1,520.652 +$53.637 PER VIAL Cytomegalovirus imm iv /vial v1, posted June 2, 2022
2Q21 $1,467.015 $0.00 PER VIAL Cytomegalovirus imm iv /vial v1, posted March 1, 2022
1Q21 $1,467.015 – PER VIAL Cytomegalovirus imm iv /vial v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files